Declan T. Chard

Declan T. Chard

Auto-generated profile, based on publicly available information

Declan T. Chard

Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, UCL, London, UK

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2018 in Annals of Neurology
Verified
Journal Article
Open access
PDF file
AEArman Eshaghi
Arman Eshaghi
FPFerran Prados
Ferran Prados
WBWallace J. Brownlee
Wallace J. Brownlee
DADaniel R. Altmann
Daniel R. Altmann
CTCarmen Tur
Carmen Tur
OGon behalf of the MAGNIMS study group
on behalf of the MAGNIMS study group
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigated whether there is a spatiotemporal pattern of GM atrophy that is associated with faster disability accumulation in MS.Methods: We analyzed 3,604 brain high‐resolution T1‐weighted magnetic resonance imaging scans from 1,417 participants: 1,214 MS patients (253 clinically isolated syndrome [CIS], 708 relapsing‐remitting [RRMS], 128 secondary‐progressive [SPMS], and 125 primary‐progressive [PPMS]), over an average follow‐up of 2.41 years (standard deviation [SD] = 1.97), and 203 healthy controls (HCs; average follow‐up = 1.83 year; SD = 1.77), attending seven European centers. Disability was assessed with the Expanded Disability Status Scale (EDSS). We obtained volumes of the deep GM (DGM), temporal, frontal, parietal, occipital and cerebellar GM, brainstem, and cerebral white matter. Hierarchical mixed models assessed annual percentage rate of regional tissue loss and identified regional volumes associated with time‐to‐EDSS progression.Results: SPMS showed the lowest baseline volumes of cortical GM and DGM. Of all baseline regional volumes, only that of the DGM predicted time‐to‐EDSS progression (hazard ratio = 0.73; 95% confidence interval, 0.65, 0.82; p < 0.001): for every standard deviation decrease in baseline DGM volume, the risk of presenting a shorter time to EDSS worsening during follow‐up increased by 27%. Of all longitudinal measures, DGM showed the fastest annual rate of atrophy, which was faster in SPMS (–1.45%), PPMS (–1.66%), and RRMS (–1.34%) than CIS (–0.88%) and HCs (–0.94%; p < 0.01). The rate of temporal GM atrophy in SPMS (–1.21%) was significantly faster than RRMS (–0.76%), CIS (–0.75%), and HCs (–0.51%). Similarly, the rate of parietal GM atrophy in SPMS (–1.24‐%) was faster than CIS (–0.63%) and HCs (–0.23%; all p values <0.05). Only the atrophy rate in DGM in patients was significantly associated with disability accumulation (beta = 0.04; p < 0.001).Interpretation: This large, multicenter and longitudinal study shows that DGM volume loss drives disability accumulation in MS, and that temporal cortical GM shows accelerated atrophy in SPMS than RRMS. The difference in regional GM atrophy development between phenotypes needs to be taken into account when evaluating treatment effect of therapeutic interventions. Ann Neurol 2018;83:210–222

20 June 2008 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
LFLeonora K. Fisniku
Leonora K. Fisniku
DCDeclan Chard
Declan Chard
JJJonathan S. Jackson
Jonathan S. Jackson
VAValerie Anderson
Valerie Anderson
DADaniel R. Altmann
Daniel R. Altmann
DMDavid H. Miller
David H. Miller

1 February 2012 in The Lancet Neurology
Verified
Journal Article
Closed access
DMDavid H Miller
David H Miller
DCDeclan T Chard
Declan T Chard
OCOlga Ciccarelli
Olga Ciccarelli

26 March 2004 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
LPLaura M. Parkes
Laura M. Parkes
WRWaqar Rashid
Waqar Rashid
DCDeclan T. Chard
Declan T. Chard
PTPaul S. Tofts
Paul S. Tofts

1 February 2002 in Brain
Verified
Journal Article
Closed access
PDF file
DCD. T. Chard
D. T. Chard
CGC. M. Griffin
C. M. Griffin
GPGeoff Parker
Geoff Parker
RKR. Kapoor
R. Kapoor
ATA. J. Thompson
A. J. Thompson
DMD. H. Miller
D. H. Miller
Brain atrophy measured by MRI is a potentially useful tool for monitoring disease progression in multiple sclerosis. The location, extent and mechanisms of brain atrophy in early disease are not well documented. Using quantitative MRI, this study investigated whole brain, grey and white matter atrophy in clinically early relapsing–remitting multiple sclerosis and its relationship to lesion measures. Data came from 27 normal control subjects (14 females and 13 males, mean age 36.1 years) and 26 subjects with clinically definite multiple sclerosis (18 females and eight males, mean age 35.1 years, mean delay from first symptom to scan 1.8 years, median Expanded Disability Status Scale score 1.0). All had three‐dimensional fast spoiled gradient recall (3D FSPGR), T1‐weighted pre‐ and post‐gadolinium‐enhanced and T2‐weighted scans. The 3D FSPGR images were automatically segmented into grey and white matter and cerebrospinal fluid using SPM99. 3D FSPGR hypo‐intense, T2 hyper‐intense, T1 hypo‐intense and T1 post‐gadolinium‐enhancing lesion volumes were determined by semi‐automatic lesion segmentation. The SPM99 output was combined with the 3D FSPGR lesion segmentations to quantify tissue volumes as fractions of total intracranial volumes, producing values for the brain parenchymal fraction (BPF), white matter fraction (WMF) and grey matter fraction (GMF). Comparing multiple sclerosis with control subjects, BPF, GMF and WMF were significantly reduced (P < 0.001 for all tissue fractions). Using Pearson correlations, T2 hyper‐intense and T1 hypo‐intense lesion volumes were inversely related to BPF (T2 r = –0.78, P < 0.001; T1 r = –0.59, P = 0.002) and GMF (T2 r = –0.73, P < 0.001; T1 r = –0.53, P = 0.006), but not WMF (T2 r = –0.30, P = 0.134; T1 r = –0.26, P = 0.199). T1 post‐gadolinium‐enhancing lesion volumes were not correlated with any fractional volumes. These results indicate that significant brain atrophy, affecting both grey and white matter, occurs early in the clinical course of multiple sclerosis. The lack of correlation between lesion load measures and WMF suggests that pathological changes in white matter may occur by mechanisms which are at least partly independent from overt lesion genesis in early multiple sclerosis.

8 May 2018 in Brain
Verified
Journal Article
Open access
PDF file
AEArman Eshaghi
Arman Eshaghi
RMRazvan V Marinescu
Razvan V Marinescu
AYAlexandra L Young
Alexandra L Young
NFNicholas C Firth
Nicholas C Firth
FPFerran Prados
Ferran Prados
OCOlga Ciccarelli
Olga Ciccarelli
See Stankoff and Louapre (doi: 10.1093/brain/awy114 ) for a scientific commentary on this article. Grey matter atrophy is present from the earliest stages of multiple sclerosis, but its temporal ordering is poorly understood. We aimed to determine the sequence in which grey matter regions become atrophic in multiple sclerosis and its association with disability accumulation. In this longitudinal study, we included 1417 subjects: 253 with clinically isolated syndrome, 708 with relapsing-remitting multiple sclerosis, 128 with secondary-progressive multiple sclerosis, 125 with primary-progressive multiple sclerosis, and 203 healthy control subjects from seven European centres. Subjects underwent repeated MRI (total number of scans 3604); the mean follow-up for patients was 2.41 years (standard deviation = 1.97). Disability was scored using the Expanded Disability Status Scale. We calculated the volume of brain grey matter regions and brainstem using an unbiased within-subject template and used an established data-driven event-based model to determine the sequence of occurrence of atrophy and its uncertainty. We assigned each subject to a specific event-based model stage, based on the number of their atrophic regions. Linear mixed-effects models were used to explore associations between the rate of increase in event-based model stages, and T2 lesion load, disease-modifying treatments, comorbidity, disease duration and disability accumulation. The first regions to become atrophic in patients with clinically isolated syndrome and relapse-onset multiple sclerosis were the posterior cingulate cortex and precuneus, followed by the middle cingulate cortex, brainstem and thalamus. A similar sequence of atrophy was detected in primary-progressive multiple sclerosis with the involvement of the thalamus, cuneus, precuneus, and pallidum, followed by the brainstem and posterior cingulate cortex. The cerebellum, caudate and putamen showed early atrophy in relapse-onset multiple sclerosis and late atrophy in primary-progressive multiple sclerosis. Patients with secondary-progressive multiple sclerosis showed the highest event-based model stage (the highest number of atrophic regions, P < 0.001) at the study entry. All multiple sclerosis phenotypes, but clinically isolated syndrome, showed a faster rate of increase in the event-based model stage than healthy controls. T2 lesion load and disease duration in all patients were associated with increased event-based model stage, but no effects of disease-modifying treatments and comorbidity on event-based model stage were observed. The annualized rate of event-based model stage was associated with the disability accumulation in relapsing-remitting multiple sclerosis, independent of disease duration (P < 0.0001). The data-driven staging of atrophy progression in a large multiple sclerosis sample demonstrates that grey matter atrophy spreads to involve more regions over time. The sequence in which regions become atrophic is reasonably consistent across multiple sclerosis phenotypes. The spread of atrophy was associated with disease duration and with disability accumulation over time in relapsing-remitting multiple sclerosis.